BOBO DONALD E JR 4

What Happened Donald E. BoBo Jr, CVP of Strategy & Corporate Development at Edwards Lifesciences (EW), sold 24,000 shares in an open-market/private sale on February 25, 2026. The weighted average sale price was $83.84 per share for total proceeds of $2,012,076. The filing notes the trades were executed across multiple transactions with prices ranging $83.66–$83.96.

Key Details

• Transaction date: 2026-02-25; Filing date (Form 4): 2026-02-26 — appears to be filed timely (within the usual 2-business-day window).
• Transaction type/code: S (sale; open market or private sale).
• Shares sold: 24,000; Weighted average price: $83.84; Total reported proceeds: $2,012,076.
• Post-transaction holdings: Not fully specified in this Form 4. The filing corrects prior reporting by moving 13,396 shares to indirect ownership (Footnote F2) and notes other plan-reported shares per the company 401(k) statement (F3).
• Notable footnotes: F1 says the sale was executed in multiple trades (prices $83.66–$83.96) and the reporting person will provide full trade-level details upon request; F2 corrects 13,396 shares as indirectly held; F3 reflects 401(k) statement shares.
• Remarks: The form states it reflects changes in beneficial ownership only and does not list other securities the reporting person may own.

Context

• This was a sale, which is often routine (liquidity, diversification, tax needs) and does not by itself indicate the insider’s view of the company. The filing supplies a weighted average and offers trade-level detail on request for those who want to verify execution specifics.